All GLP-1 medications from licensed 503A compounding pharmacies Browse Products

Weight gain on Zepbound: the usual non-drug causes and when to see a doctor

Gaining weight on Zepbound is rarely the drug itself. Water retention, calorie intake, dose cuts and new medications are likelier. See next steps.

By FormBlends Editorial Research|Reviewed by FormBlends Medical Team||

This article is part of our Safety & Quality collection. See also: Peptide Guides | GLP-1 Guides

See your personalized options in about 2 minutes. Free and private. See my options →

Can tirzepatide cause weight gain?
Direct pharmacological gain is uncommon; behavioral or external factors more typical.

Is water retention common?
Yes, especially in first weeks or with diet changes.

Could I be eating too much without realizing?
Yes; food log frequently reveals this.

Was my dose reduced?
Reduction often correlates with slower progress or modest regain.

Could a new medication be causing it?
Yes; SSRIs, antipsychotics, steroids, others.

Does perimenopause affect weight on Zepbound?
Yes; hormonal transitions affect body composition.

Can stress cause weight gain?
Yes; cortisol pathway and emotional eating.

When should I see my doctor?
Sustained gain on consistent therapy, associated symptoms, or significant distress.

Could I be a non-responder?
~14% of SURMOUNT-1 patients lost under 5%; modest-responder biology is real.

  1. Zepbound FDA prescribing information
  2. Mounjaro FDA prescribing information
  3. Tasali E et al., JAMA Internal Medicine, March 2022
  4. American Thyroid Association screening guidelines
  5. American Academy of Sleep Medicine sleep apnea guidance
  6. American College of Endocrinology obesity consensus statements
  7. Jastreboff AM et al. Tirzepatide Once Weekly for the Treatment of Obesity. N Engl J Med. 2022.
  8. Aronne LJ et al. Continued Treatment With Tirzepatide for Maintenance of Weight Reduction in Adults With Obesity: The SURMOUNT-4 Randomized Clinical Trial. JAMA. 2024.

Platform Disclaimer. FormBlends connects patients with licensed clinicians. This article is educational. Individual situations require clinical assessment by your prescriber.

Compounded Medication Notice. Compounded tirzepatide is available through 503A pharmacy partners for individual patients with documented clinical justification. Not FDA-approved. SURMOUNT trial data applies to brand Zepbound and Mounjaro.

Results Disclaimer. Individual outcomes vary. Weight regulation involves multiple factors. SURMOUNT-1 mean weight loss represents group averages with wide distribution.

Trademark Notice. Zepbound, Mounjaro, SURMOUNT are trademarks of Eli Lilly and Company. FormBlends is independent.

See your options in about 2 minutes

Take the free quiz and see what fits you. Quick, private, and no commitment to continue.

See my options →

Weight-related adverse event reports across GLP-1 medications

Reported counts in the FDA Adverse Event Reporting System for weight-related terms across tirzepatide, semaglutide, and liraglutide.

All reportsWeight increasedWeight decreasedWeight loss poorWeight fluctuation
Tirzepatide181,0684,035 (2.2%)2,596 (1.4%)108 (0.06%)177 (0.10%)
Semaglutide78,0232,869 (3.7%)4,777 (6.1%)582 (0.75%)170 (0.22%)
Liraglutide51,3031,270 (2.5%)2,166 (4.2%)478 (0.93%)51 (0.10%)

openFDA data updated 2026-10-28. A report means someone linked a symptom to a drug, not that the drug caused it, and report counts cannot give a rate among all users. Terms are MedDRA preferred terms.

Source: openFDA drug adverse event endpoint (FAERS), patient.drug.openfda.generic_name and reactionmeddrapt.exact counts (accessed 2026-11-16)

Questions about weight changes on Zepbound

Clinical trials and FDA adverse event reports document how body weight responds to tirzepatide and how often unexpected weight changes are reported.

How often is weight gain reported on tirzepatide?

In the FDA Adverse Event Reporting System (FAERS), 4,035 of 181,068 reports naming tirzepatide list weight increased (2.2%). Reports also list drug ineffective in 8,287 cases (4.6%), weight fluctuation in 177 cases (0.10%), and poor weight loss in 108 cases (0.06%).

What weight changes were measured across different doses in trials?

In the SURMOUNT-1 trial, average body weight change at week 72 was -16.0% on 5 mg tirzepatide, -21.4% on 10 mg, and -22.5% on 15 mg, compared to -2.4% on placebo. In addition, 89.41% of participants on 5 mg, 96.18% on 10 mg, and 96.32% on 15 mg achieved at least a 5% weight reduction, compared to 27.87% on placebo.

Can dose errors explain unexpected weight results?

Dosing issues appear in FDA surveillance records. Across 181,068 FAERS reports naming tirzepatide, incorrect dose administered is listed in 32,155 reports (17.8%). In addition, product dose omission issue is cited in 5,418 reports (3.0%) and accidental underdose in 4,610 reports (2.5%).

Sources: openFDA drug adverse event endpoint (FAERS), patient.drug.openfda.generic_name and reactionmeddrapt.exact counts (accessed 2026-11-16); ClinicalTrials.gov, NCT04184622 (accessed 2026-11-16)

Why you may be gaining weight on Zepbound and when to call
FormBlends guide cover for Why you may be gaining weight on Zepbound and when to call.

Continue with decision-grade research

Compare the options behind this question

These pages separate verified facts, commercial terms, and unresolved claims so you can check the evidence before choosing a provider.

GLP-1 decision path

Use this page to decide if a provider review is the right next step

Related treatment context

Why you may be gaining weight on Zepbound and when to call research is most useful when it helps you compare eligibility, expected results, side effects, cost, and the supervision needed before treatment.

Evidence check

The strongest GLP-1 pages connect the practical answer to clinical trials, FDA labeling where applicable, and real access constraints.

Safety check

A licensed clinician still needs to review health history, contraindications, current medications, side effects, and dose escalation.

Next step

When the page matches your goal, continue into the FormBlends get-started flow so the intake can route you toward the right prescription review path.

Original tools and data

Use FormBlends tools and data

Compare provider prices, explore local access and check calculations using FormBlends tools and data.

Download the Medication Safety Checklist

A printable checklist for verifying pharmacy credentials, reading COAs, and safe injection practices.

Free download. We'll also send helpful GLP-1 guides to your inbox. Unsubscribe anytime.

Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before starting, stopping, or changing any medication or treatment. FormBlends articles are source-checked against medical and regulatory references, but they are not a substitute for a personal medical consultation.

Written by FormBlends Editorial Research

Prepared by FormBlends Editorial Research.

Ready to get started?

Provider-reviewed GLP-1 and peptide therapy, delivered to your door.

Start Your Consultation

Ready to Start Your Weight Loss Journey?

Get a free medical consultation with a licensed provider. Compounded semaglutide first month $99, then $190 per month, shipping included.

Next Best Reads

Safety & Quality

Why Am I Gaining Weight on Semaglutide? Causes and Course Correction

Gaining weight on semaglutide is uncommon and rarely caused by the medication directly. Includes 2026 evidence, safety boundaries, and what to verify with a.

Safety & Quality

Why Am I Gaining Weight on Ozempic? The Counterintuitive Explanations

Why Am I Gaining Weight on Ozempic? The Counterintuitive Explanations explained with current evidence and patient-safety context.

GLP-1 Weight Loss

Why Am I Gaining Weight on Mounjaro? Female-Specific Causes, Hormonal Factors, and the Fix Protocol

Why women gain weight on Mounjaro despite compliance, the hormonal factors most articles miss, and the diagnostic protocol to identify your specific cause.

Lifestyle & Wellness

Night Eating Syndrome Gaining Weight

Night Eating Syndrome Gaining Weight. Exploring the mental and emotional aspects of weight loss on GLP-1 therapy. Evidence-based guidance from FormBlends.

GLP-1 Weight Loss

Why Am I Not Losing Weight On Zepbound?

Not losing weight on Zepbound? Common causes include subtherapeutic dosing, medication conflicts, and metabolic conditions.

Lifestyle & Wellness

Sedentary Job Gaining Weight Fast

Sedentary Job Gaining Weight Fast. Exploring the mental and emotional aspects of weight loss on GLP-1 therapy. Evidence-based guidance from FormBlends.

Lifestyle & Wellness

Night Shift Gaining Weight Disrupted Schedule

Struggling with night shift weight gain? You are not alone, and there are real solutions. Learn about the connection between weight and this challenge, and how medical support can help.

Lifestyle & Wellness

Desk Job Sitting All Day Gaining Weight

Struggling with desk job sitting weight? You are not alone, and there are real solutions. Learn about the connection between weight and this challenge, and how medical support can help.

Safety & Quality

Why Am I Not Losing Weight on Zepbound? Plateau Realities and Course Correction

Common causes for not losing weight on Zepbound include being early in titration at sub-therapeutic doses, eating patterns offsetting.

FormBlends for iPhone

Track your routine in the FormBlends app

Doses, schedules, reminders, meals and progress in one free iPhone app.

Free Tools

Calculators to support your weight loss journey.